Cargando…
Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915108/ https://www.ncbi.nlm.nih.gov/pubmed/33557446 http://dx.doi.org/10.3390/cancers13040623 |
| _version_ | 1783657160740175872 |
|---|---|
| author | Hu, Wen Zhang, Li Ferri-Borgogno, Sammy Kwan, Suet-Ying Lewis, Kelsey E. Cun, Han T. Yeung, Tsz-Lun Soliman, Pamela T. Tarapore, Rohinton S. Allen, Joshua E. Guan, Xinyuan Lu, Karen H. Mok, Samuel C. Au-Yeung, Chi-Lam |
| author_facet | Hu, Wen Zhang, Li Ferri-Borgogno, Sammy Kwan, Suet-Ying Lewis, Kelsey E. Cun, Han T. Yeung, Tsz-Lun Soliman, Pamela T. Tarapore, Rohinton S. Allen, Joshua E. Guan, Xinyuan Lu, Karen H. Mok, Samuel C. Au-Yeung, Chi-Lam |
| author_sort | Hu, Wen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7915108 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79151082021-03-01 Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436 Hu, Wen Zhang, Li Ferri-Borgogno, Sammy Kwan, Suet-Ying Lewis, Kelsey E. Cun, Han T. Yeung, Tsz-Lun Soliman, Pamela T. Tarapore, Rohinton S. Allen, Joshua E. Guan, Xinyuan Lu, Karen H. Mok, Samuel C. Au-Yeung, Chi-Lam Cancers (Basel) Correction MDPI 2021-02-04 /pmc/articles/PMC7915108/ /pubmed/33557446 http://dx.doi.org/10.3390/cancers13040623 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Correction Hu, Wen Zhang, Li Ferri-Borgogno, Sammy Kwan, Suet-Ying Lewis, Kelsey E. Cun, Han T. Yeung, Tsz-Lun Soliman, Pamela T. Tarapore, Rohinton S. Allen, Joshua E. Guan, Xinyuan Lu, Karen H. Mok, Samuel C. Au-Yeung, Chi-Lam Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436 |
| title | Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436 |
| title_full | Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436 |
| title_fullStr | Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436 |
| title_full_unstemmed | Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436 |
| title_short | Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436 |
| title_sort | correction: hu, w., et al. targeting dopamine receptor d2 by imipridone suppresses uterine serous cancer malignant phenotype. cancers 2020, 12, 2436 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915108/ https://www.ncbi.nlm.nih.gov/pubmed/33557446 http://dx.doi.org/10.3390/cancers13040623 |
| work_keys_str_mv | AT huwen correctionhuwetaltargetingdopaminereceptord2byimipridonesuppressesuterineserouscancermalignantphenotypecancers2020122436 AT zhangli correctionhuwetaltargetingdopaminereceptord2byimipridonesuppressesuterineserouscancermalignantphenotypecancers2020122436 AT ferriborgognosammy correctionhuwetaltargetingdopaminereceptord2byimipridonesuppressesuterineserouscancermalignantphenotypecancers2020122436 AT kwansuetying correctionhuwetaltargetingdopaminereceptord2byimipridonesuppressesuterineserouscancermalignantphenotypecancers2020122436 AT lewiskelseye correctionhuwetaltargetingdopaminereceptord2byimipridonesuppressesuterineserouscancermalignantphenotypecancers2020122436 AT cunhant correctionhuwetaltargetingdopaminereceptord2byimipridonesuppressesuterineserouscancermalignantphenotypecancers2020122436 AT yeungtszlun correctionhuwetaltargetingdopaminereceptord2byimipridonesuppressesuterineserouscancermalignantphenotypecancers2020122436 AT solimanpamelat correctionhuwetaltargetingdopaminereceptord2byimipridonesuppressesuterineserouscancermalignantphenotypecancers2020122436 AT taraporerohintons correctionhuwetaltargetingdopaminereceptord2byimipridonesuppressesuterineserouscancermalignantphenotypecancers2020122436 AT allenjoshuae correctionhuwetaltargetingdopaminereceptord2byimipridonesuppressesuterineserouscancermalignantphenotypecancers2020122436 AT guanxinyuan correctionhuwetaltargetingdopaminereceptord2byimipridonesuppressesuterineserouscancermalignantphenotypecancers2020122436 AT lukarenh correctionhuwetaltargetingdopaminereceptord2byimipridonesuppressesuterineserouscancermalignantphenotypecancers2020122436 AT moksamuelc correctionhuwetaltargetingdopaminereceptord2byimipridonesuppressesuterineserouscancermalignantphenotypecancers2020122436 AT auyeungchilam correctionhuwetaltargetingdopaminereceptord2byimipridonesuppressesuterineserouscancermalignantphenotypecancers2020122436 |